Certificates of analysis
COAs
Every listed size has a reserved lot number and a certificate slot. When a third-party laboratory issues a certificate for a lot, it is linked here as “View COA.” Until then, the slot reads “COA pending, published after third-party testing.”
COA library
| Product | Size | Lot | Certificate |
|---|---|---|---|
| Semax | 5 mg | SI-SMX-5-2611-001 | COA pending, published after third-party testing |
| Semax | 10 mg | SI-SMX-10-2611-001 | COA pending, published after third-party testing |
| Semax | 30 mg | SI-SMX-30-2611-001 | COA pending, published after third-party testing |
| MOTS-c | 5 mg | SI-MOT-5-2611-001 | COA pending, published after third-party testing |
| MOTS-c | 10 mg | SI-MOT-10-2611-001 | COA pending, published after third-party testing |
| MOTS-c | 20 mg | SI-MOT-20-2611-001 | COA pending, published after third-party testing |
| MOTS-c | 30 mg | SI-MOT-30-2611-001 | COA pending, published after third-party testing |
| GHK-Cu | 100 mg | SI-GHK-100-2611-001 | COA pending, published after third-party testing |
| Tesamorelin | 5 mg | SI-TES-5-2611-001 | COA pending, published after third-party testing |
| Tesamorelin | 10 mg | SI-TES-10-2611-001 | COA pending, published after third-party testing |
| Tesamorelin | 20 mg | SI-TES-20-2611-001 | COA pending, published after third-party testing |
| CJC-1295 (no DAC) + Ipamorelin | 10 mg | SI-CJI-10-2611-001 | COA pending, published after third-party testing |
| CJC-1295 (DAC) | 5 mg | SI-CJD-5-2611-001 | COA pending, published after third-party testing |
| CJC-1295 (DAC) | 10 mg | SI-CJD-10-2611-001 | COA pending, published after third-party testing |
| CJC-1295 (no DAC) | 5 mg | SI-CJC-5-2611-001 | COA pending, published after third-party testing |
| CJC-1295 (no DAC) | 10 mg | SI-CJC-10-2611-001 | COA pending, published after third-party testing |
| Sermorelin | 5 mg | SI-SRM-5-2611-001 | COA pending, published after third-party testing |
| Sermorelin | 10 mg | SI-SRM-10-2611-001 | COA pending, published after third-party testing |
| Ipamorelin | 5 mg | SI-IPA-5-2611-001 | COA pending, published after third-party testing |
| Ipamorelin | 10 mg | SI-IPA-10-2611-001 | COA pending, published after third-party testing |
| KLOW | 80 mg | SI-KLW-80-2611-001 | COA pending, published after third-party testing |
| GLOW | 70 mg | SI-GLW-70-2611-001 | COA pending, published after third-party testing |
| KPV | 5 mg | SI-KPV-5-2611-001 | COA pending, published after third-party testing |
| KPV | 10 mg | SI-KPV-10-2611-001 | COA pending, published after third-party testing |
| KPV | 30 mg | SI-KPV-30-2611-001 | COA pending, published after third-party testing |
| SS-31 | 10 mg | SI-SS3-10-2611-001 | COA pending, published after third-party testing |
| Tirzepatide | 10 mg | SI-TRZ-10-2611-001 | COA pending, published after third-party testing |
| Tirzepatide | 15 mg | SI-TRZ-15-2611-001 | COA pending, published after third-party testing |
| Tirzepatide | 20 mg | SI-TRZ-20-2611-001 | COA pending, published after third-party testing |
| Tirzepatide | 30 mg | SI-TRZ-30-2611-001 | COA pending, published after third-party testing |
| Retatrutide | 10 mg | SI-RET-10-2611-001 | COA pending, published after third-party testing |
| Retatrutide | 15 mg | SI-RET-15-2611-001 | COA pending, published after third-party testing |
| Retatrutide | 20 mg | SI-RET-20-2611-001 | COA pending, published after third-party testing |
| Retatrutide | 30 mg | SI-RET-30-2611-001 | COA pending, published after third-party testing |
| Retatrutide | 40 mg | SI-RET-40-2611-001 | COA pending, published after third-party testing |
| PT-141 | 5 mg | SI-PT1-5-2611-001 | COA pending, published after third-party testing |
| PT-141 | 10 mg | SI-PT1-10-2611-001 | COA pending, published after third-party testing |
| BPC-157 | 5 mg | SI-BPC-5-2611-001 | COA pending, published after third-party testing |
| BPC-157 | 10 mg | SI-BPC-10-2611-001 | COA pending, published after third-party testing |
| BPC-157 | 20 mg | SI-BPC-20-2611-001 | COA pending, published after third-party testing |
| BPC-157 | 30 mg | SI-BPC-30-2611-001 | COA pending, published after third-party testing |
| TB-500 | 5 mg | SI-TB5-5-2611-001 | COA pending, published after third-party testing |
| TB-500 | 10 mg | SI-TB5-10-2611-001 | COA pending, published after third-party testing |
| TB-500 | 20 mg | SI-TB5-20-2611-001 | COA pending, published after third-party testing |
| NAD+ | 500 mg | SI-NAD-500-2611-001 | COA pending, published after third-party testing |
| BPC-157 + TB-500 | 10 mg | SI-BTB-10-2611-001 | COA pending, published after third-party testing |
| BPC-157 + TB-500 | 20 mg | SI-BTB-20-2611-001 | COA pending, published after third-party testing |
| Kisspeptin | 5 mg | SI-KIS-5-2611-001 | COA pending, published after third-party testing |
| Melanotan II | 10 mg | SI-MT2-10-2611-001 | COA pending, published after third-party testing |
| Selank | 5 mg | SI-SLK-5-2611-001 | COA pending, published after third-party testing |
| Selank | 10 mg | SI-SLK-10-2611-001 | COA pending, published after third-party testing |
| Selank | 30 mg | SI-SLK-30-2611-001 | COA pending, published after third-party testing |
| Semaglutide | 5 mg | SI-SMG-5-2611-001 | COA pending, published after third-party testing |
| Semaglutide | 10 mg | SI-SMG-10-2611-001 | COA pending, published after third-party testing |
| Semaglutide | 15 mg | SI-SMG-15-2611-001 | COA pending, published after third-party testing |
| Semaglutide | 20 mg | SI-SMG-20-2611-001 | COA pending, published after third-party testing |
| Semaglutide | 30 mg | SI-SMG-30-2611-001 | COA pending, published after third-party testing |
| Epithalon | 5 mg | SI-EPI-5-2611-001 | COA pending, published after third-party testing |
| Epithalon | 10 mg | SI-EPI-10-2611-001 | COA pending, published after third-party testing |
| Epithalon | 20 mg | SI-EPI-20-2611-001 | COA pending, published after third-party testing |
| BAC Water | 10 mL | SI-BAC-10ML-2611-001 | COA pending, published after third-party testing |